ANGELA STINSON: Open Payments
NPI 1528050853 · SOMERSET, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,175 in 169 payments from 15 companies in 2025. Trend: 2023 $2,267 · 2024 $2,988 · 2025 $3,175
Food & beverage: $3,175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $788 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $348 |
| Phathom Pharmaceuticals, Inc. | 30 | $308 |
| Janssen Biotech, Inc. | 13 | $280 |
| Madrigal Pharmaceuticals | 8 | $250 |
| GENZYME CORPORATION | 13 | $194 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $189 |
| Regeneron Healthcare Solutions, Inc. | 7 | $167 |
| Aimmune Therapeutics, Inc. | 12 | $159 |
| EVOKE PHARMA, INC. | 3 | $147 |
Products named: DUPIXENT, XIFAXAN, VOQUEZNA, RINVOQ, TREMFYA, REZDIFFRA, LINZESS, ENTYVIO.
Industry payments across KY — which companies pay providers there.
